Ujwal Shetty

Ujwal Shetty

Auto-generated profile, based on publicly available information

Ujwal Shetty

Manipal Institute of Virology, Manipal Academy of Higher Education

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2024 in Annals of Medicine
Verified
Journal Article
Open access
PPPragathi P.
Pragathi P.
USUjwal Shetty
Ujwal Shetty
PPPreetiparna Parida
Preetiparna Parida
PVPrasad Varamballi
Prasad Varamballi
Chiranjay MukhopadhyayChiranjay Mukhopadhyay
Chiranjay Mukhopadhyay
SNSudheesh N.
Sudheesh N.
Human metapneumovirus (HMPV) is a common respiratory pathogen that causes respiratory tract infections. In India, HMPV has been identified as one of the leading causes of morbidity and mortality in infants and young children with respiratory tract infections. The most reported sublineages of HMPV in India are B1, B2, A2b and A2c. A retrospective study was conducted to determine the circulating genotypes of HMPV among SARI cases from January 2016 to December 2018. Positive throat swab samples were confirmed with real-time RT-PCR. Subsequently, these samples were analysed using semi-nested conventional RT-PCR targeting the G gene, followed by sequencing and phylogenetic analysis. Clinical data analysis was also performed using SPSS 15.0 software. All 20 samples from the SARI cases were classified under the A2c sublineage of HMPV. Phylogenetic analysis indicated that these strains were genetically related to those circulating in Japan, China, and Croatia. Among the samples, ten showed 111-nucleotide duplications, while the other ten had 180-nucleotide duplications. Clinical analysis showed that four cases had coinfections with other pathogens. Our extensive analysis of patient samples determined that HMPV, especially the A2c genotype, significantly contributed to SARI cases within our study population, which signifies the importance of considering HMPV as a probable aetiological agent when investigating SARI outbreaks.

Verified
Journal Article
Open access
PDF file
AJAnup Jayaram
Anup Jayaram
AJAnitha Jagadesh
Anitha Jagadesh
AKAjay Kumar
Ajay Kumar
HDHayk Davtyan
Hayk Davtyan
PTPruthu Thekkur
Pruthu Thekkur
Chiranjay MukhopadhyayChiranjay Mukhopadhyay
Chiranjay Mukhopadhyay
The COVID-19 pandemic and public health response to the pandemic has caused huge setbacks in the management of other infectious diseases. In the present study, we aimed to (i) assess the trends in numbers of samples from patients with influenza-like illness and severe acute respiratory syndrome tested for influenza and the number and proportion of cases detected from 2015–2021 and (ii) examine if there were changes during the COVID-19 period (2020–2021) compared to the pre-COVID-19 period (2015–2019) in three states of India. The median (IQR) number of samples tested per month during the pre-COVID-19 period was 653 (395–1245), compared to 27 (11–98) during the COVID-19 period (p value < 0.001). The median (IQR) number of influenza cases detected per month during the pre-COVID-19 period was 190 (113–372), compared to 29 (27–30) during the COVID-19 period (p value < 0.001). Interrupted time series analysis (adjusting for seasonality and testing charges) confirmed a significant reduction in the total number of samples tested and influenza cases detected during the COVID-19 period. However, there was no change in the influenza positivity rate between pre-COVID-19 (29%) and COVID-19 (30%) period. These findings suggest that COVID-19-related disruptions, poor health-seeking behavior, and overburdened health systems might have led to a reduction in reported influenza cases rather than a true reduction in disease transmission.

1 February 2018 in Antiviral Therapy
Verified
Journal Article
Closed access
RVRaksha Vikas
Raksha Vikas
SPSuresha G Prabhu
Suresha G Prabhu
PMPiya P Mudgal
Piya P Mudgal
USUjwal Shetty
Ujwal Shetty
KKKavitha Karunakaran
Kavitha Karunakaran
AGArunkumar Govindakarnavar
Arunkumar Govindakarnavar
Background: Infections due to drug-resistant herpes simplex viruses (HSV) represent an important clinical concern, especially in immunocompromised patients. The present study was aimed at detecting acyclovir (ACV) susceptibility in HSV clinical samples. Methods: A total of 13 HSV-positive clinical samples (5 HSV-1 and 8 HSV-2) recovered from patients (1 immunocompromised and 12 of unknown immune status) were included in the study. The genotypic analysis involved an initial UL23 (thymidine kinase) gene sequencing, followed by a confirmatory phenotypic assay using plaque reduction technique. Results: Two novel amino acid changes, A37V and H283N, were detected in HSV-1 positive clinical samples, which were found to be susceptible to acyclovir (half maximal effective concentration = 1.5 μM) by plaque reduction assay. Conclusions: These two novel amino acid changes could be therefore considered as natural polymorphisms, a phenomenon widely associated with the HSV-UL23 gene.

9 January 2026 in Critical Public Health
Verified
Journal Article
Open access
CKChandana H K
Chandana H K
SNSudheesh N.
Sudheesh N.
USUjwal Shetty
Ujwal Shetty
PVPrasad Varamballi
Prasad Varamballi
ABAnand Bhaskar
Anand Bhaskar
Chiranjay MukhopadhyayChiranjay Mukhopadhyay
Chiranjay Mukhopadhyay